BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27105541)

  • 21. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.
    Opfermann KJ; Wahlquist AE; Garrett-Mayer E; Shridhar R; Cannick L; Marshall DT
    Am J Clin Oncol; 2014 Apr; 37(2):112-6. PubMed ID: 23211221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.
    Wu SG; Sun JY; Zhou J; Li FY; Zhou H; Lin Q; Lin HX; Bao Y; He ZY
    Radiat Oncol; 2014 Dec; 9():284. PubMed ID: 25511525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer.
    He M; Zhang JX; Jiang YZ; Chen YL; Yang HY; Tang LC; Shao ZM; Di GH
    Oncotarget; 2017 Jul; 8(27):44870-44880. PubMed ID: 28496004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LODDS is superior to lymph node ratio for the prognosis of node-positive rectal cancer patients treated with preoperative radiotherapy.
    Huang B; Ni M; Chen C; Cai G; Cai S
    Tumori; 2017 Jan; 103(1):87-92. PubMed ID: 27716883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
    Hong R; Dai Z; Zhu W; Xu B
    PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
    Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY
    Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.
    Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C
    J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).
    Wei WJ; Lu ZW; Wen D; Liao T; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
    World J Surg; 2018 Jun; 42(6):1762-1771. PubMed ID: 29185020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The intrathoracic lymph node ratio seems to be a better prognostic factor than the level of lymph node involvement in lung metastasectomy of colorectal carcinoma.
    Renaud S; Falcoz PE; Olland A; Schaeffer M; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):215-21. PubMed ID: 25358477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?
    Yoshida K; Kajiyama H; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Utsumi F; Niimi K; Suzuki S; Kikkawa F
    Int J Clin Oncol; 2019 May; 24(5):567-574. PubMed ID: 30612268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph Node Ratio Can Better Predict Prognosis than Absolute Number of Positive Lymph Nodes in Operable Cervical Carcinoma.
    Widschwendter P; Polasik A; Janni W; de Gregorio A; Friedl TWP; de Gregorio N
    Oncol Res Treat; 2020; 43(3):87-95. PubMed ID: 31935729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.
    Wei C; Deng WY; Li N; Shen W; Zhang C; Liu JY; Luo SX
    Dig Dis Sci; 2015 Sep; 60(9):2771-6. PubMed ID: 25939544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer.
    Lei BW; Hu JQ; Yu PC; Wang YL; Wei WJ; Zhu J; Shi X; Qu N; Lu ZW; Ji QH
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3425-3434. PubMed ID: 31511971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel grade-lymph node ratio model predicts the prognosis of the advanced gastric cancer patients after neoadjuvant radiotherapy.
    Liu J; Su M; Wang J; Zhang G; Zhou J; Zhang A; Ren Z; Zheng X; Hong S; Wang S; Zhang R
    Oncotarget; 2017 Feb; 8(8):14058-14067. PubMed ID: 27740935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of lymph node ratio on survival in papillary thyroid cancer.
    Schneider DF; Chen H; Sippel RS
    Ann Surg Oncol; 2013 Jun; 20(6):1906-11. PubMed ID: 23263904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
    Lee YY; Park W; Huh SJ; Yoon A; Park JY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
    Anticancer Res; 2013 Oct; 33(10):4675-81. PubMed ID: 24123048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node ratio predicts the benefit of post-operative radiotherapy in oral cavity cancer.
    Urban D; Gluck I; Pfeffer MR; Symon Z; Lawrence YR
    Radiother Oncol; 2013 Jan; 106(1):74-9. PubMed ID: 23157979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.